Barclays PLC Dexcom Inc Call Options Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $59.4 Million - $75.6 Million	538,200 New	538,200 $61 Million
Q4 2023 Feb 15, 2024	BUY	$75.49 - $124.16 $4.04 Million - $6.64 Million	53,500 New	53,500 $6.64 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $186,956 - $269,874	2,200 New	2,200 $249,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $5.83 Million - $7.31 Million	-44,900 Reduced 89.8%	5,100 $2.74 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $2.93 Million - $3.93 Million	37,600 Added 303.23%	50,000 $18.5 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $714,552 - $1.2 Million	11,400 Added 1140.0%	12,400 $5.03 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $1.66 Million - $2.62 Million	-34,700 Reduced 97.2%	1,000 $269,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $275,616 - $385,308	9,900 Added 38.37%	35,700 $5.35 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $693,329 - $943,046	24,700 Added 2245.45%	25,800 $3.07 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $577,586 - $799,718	-21,400 Reduced 95.11%	1,100 $132,000
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $396,950 - $624,240	-17,000 Reduced 43.04%	22,500 $3.22 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $636,702 - $915,486	36,300 Added 1134.38%	39,500 $3.75 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $35,584 - $49,216	3,200	3,200 $184,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.